ID: h-SDA-2026-04-26-gap-debate-20260426-011
Hypothesis

Endothelial miR-181c-5p Upregulation Drives Claudin-5 Repression and Paracellular BBB Dysfunction in Preclinical Alzheimer's Disease

Circulating miR-181c-5p is upregulated in AD patients and directly targets the CLDN5 3'-UTR, suppressing claudin-5 expression in brain endothelial cells.
🧬 CLDN5 (Claudin-5) - regulated by miR-181c-5p🎯 Composite 64%💱 $0.55▼9.6%proposed
neurodegeneration
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.44 (15%) Evidence 0.43 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.70 (5%) KG Connect 0.50 (8%) 0.645 composite

🧪 Overview

Circulating miR-181c-5p is upregulated in AD patients and directly targets the CLDN5 3'-UTR, suppressing claudin-5 expression in brain endothelial cells. This leads to tight junction disruption and paracellular leakage. Major weaknesses: non-specific miRNA origin (multiple cell types), no evidence that plasma miRNA crosses BBB to reach endothelial cells, and CLDN5 knockout mice show only mild BBB phenotypes.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["miR-181c-5p<br/>Upregulation"]
    B["CLDN5 (Claudin-5)<br/>mRNA Targeting"]
    C["Tight Junction<br/>Protein Downregulation"]
    D["BBB<br/>Disassembly"]
    E["Neurovascular<br/>Uncoupling"]
    F["Neuroinflammation<br/>Microglial Activation"]
    G["Cognitive<br/>Impairment"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    style A fill:#6a1b9a,stroke:#ce93d8,color:#ce93d8
    style B fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix3 supports3 contradicts
Supports
miR-181c-5p elevation identified in AD plasma samples
Supports
miR-181c targets CLDN5 and impairs endothelial barrier function
Supports
CLDN5 reduction in early AD brain vasculature
Contradicts
CLDN5 expression maintained or increased in AD frontal cortex vasculature
Contradicts
Complete CLDN5 knockout mice demonstrate only mild BBB phenotypes under baseline conditions
Contradicts
miR-181c-5p targeting of CLDN5 demonstrated only in cell lines, not in vivo
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CLDN5

No curated PDB or AlphaFold mapping for CLDN5 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for CLDN5 (Claudin-5) - regulated by miR-181c-5p from GTEx v10.

Spinal cord cervical c-169.0 Substantia nigra65.1 Hippocampus53.0 Hypothalamus50.9 Putamen basal ganglia50.5 Cortex50.3 Caudate basal ganglia45.5 Frontal Cortex BA941.4 Amygdala38.4 Cerebellum35.5 Anterior cingulate cortex BA2435.2 Nucleus accumbens basal ganglia31.8 Cerebellar Hemisphere27.7median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CLDN5 (Claudin-5) - regulated by miR-181c-5p →

No DepMap CRISPR Chronos data found for CLDN5 (Claudin-5) - regulated by miR-181c-5p.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Medium
0.0301
Events (7d)
1
Price History
▼9.6%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations1 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
If miR-181c-5p upregulation drives claudin-5 repression and paracellular BBB dysfunction, then miR-181c-5p levels in endothelial EVs will predict BBB integrity (Qalb, DCE-MRI Ktrans) and cognitive decIn matched patient samples (n≥80), endothelial EV miR-181c-5p (CD31+CD144+ EVs) inversely correlates with brain CLDN5 mRNA expression (r<-0.45, postmortem tissu— no observation —pending0.71
🔮 Falsifiable Predictions (1)
pendingconf —
If miR-181c-5p upregulation drives claudin-5 repression and paracellular BBB dysfunction, then miR-181c-5p levels in endothelial EVs will predict BBB integrity (Qalb, DCE-MRI Ktrans) and cognitive decline in neurodegeneration, with claudin-5 expression inversely correlated in brain endothelial tissu
Predicted outcome: In matched patient samples (n≥80), endothelial EV miR-181c-5p (CD31+CD144+ EVs) inversely correlates with brain CLDN5 mRNA expression (r<-0.45, postmo
Falsification: Endothelial EV miR-181c-5p does not correlate with claudin-5 expression, BBB integrity, or cognitive trajectory; claudin-5 expression is driven by other regulators (TNF-alpha, VEGF) independently of m
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.